Don’t Give Up on Biosimilars—Congress Can Give Them a Boost

Biologic drugs are one of this century’s great medical triumphs. They’ve reshaped the treatment of diverse and debilitating diseases from cancer to multiple sclerosis to heart attacks.

Continue reading on The Wall Street Journal.